Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by hyperthyroidism

Kubota, K.; Kurabayashi, H.; Tamura, J.; Kawada, E.; Tamura, K.; Nagashima, K.; Shirakura, T.

Journal of Medicine 23(1): 75-77

1992


ISSN/ISBN: 0025-7850
PMID: 1573342
Document Number: 389030
We report on a 74-year-old female patient with primary hemochromatosis complicated by hyperthyroidism. The serum ferritin level was reduced throughout a 217 day administration of deferoxamine (1 g/day). At the same time, the thyroid gland was changed from hyper- to hypo- functional proportionally.

Document emailed within 1 workday
Secure & encrypted payments